1-7 of 7
Samantha Slaff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Fedratinib Versus Best Available Therapy on Patient-Reported Outcomes in Patients with Myelofibrosis Who Were Previously Treated with Ruxolitinib: Results from the Phase 3 FREEDOM2 Trial

Claire Harrison, Jennifer Lord-Bessen, Ling Shi, Shien Guo, Aylin Yucel, Dorothy Zissler, Shalon Jones, Samantha Slaff
Journal: Blood
Blood (2024) 144 (Supplement 1): 6624.
https://doi.org/10.1182/blood-2024-198368
Published: 2024
Journal Articles

Patient Characteristics, Treatment Patterns, and Health Outcomes in a Real-World Population of Patients with Myelofibrosis Treated with Fedratinib

Francesco Passamonti, Rohan C. Parikh, Siddhi Korgaonkar, Manoj Chevli, Samantha Slaff, Julien Rombi, Basirat Adeyemi, Keith L. Davis, Aylin Yucel
Journal: Blood
Blood (2023) 142 (Supplement 1): 2425.
https://doi.org/10.1182/blood-2023-173420
Published: 2023
Journal Articles

Pomalidomide, Dexamethasone, and Daratumumab Versus Other Triplet Regimens in Patients with Relapsed or Refractory Multiple Myeloma: A Population-Adjusted Indirect Treatment Comparison

Faiz Anwer, Tommy Lan, Michael Dolph, Hoora Moradian, Samantha Slaff, Yu-Hsuan Shih, Derek Tang
Journal: Blood
Blood (2023) 142 (Supplement 1): 7345.
https://doi.org/10.1182/blood-2023-173944
Published: 2023
Journal Articles

Outcomes of Second-Line (2L) Triplet+ Regimens in Patients with Relapsed/Refractory Multiple Myeloma (MM) Following Progression after First-Line (1L) Lenalidomide in the Connect® MM Disease Registry

Hans C. Lee, Rafat Abonour, Sikander Ailawadhi, Brian G.M. Durie, Cristina J. Gasparetto, James W. Hardin, Mohit Narang, James Omel, Robert M. Rifkin, Howard Terebelo, Kathleen Toomey, Lynne I. Wagner, Samantha Slaff, Dailan Danforth, Weiyuan Chung, Jasmeet Anand, Edward Yu, Derek Tang, Sundar Jagannath
Journal: Blood
Blood (2022) 140 (Supplement 1): 13256–13258.
https://doi.org/10.1182/blood-2022-158197
Published: 2022
Journal Articles

Trends over Time in Overall Survival of Patients with Multiple Myeloma By Race/Ethnicity and By Comorbidity Status: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Analysis

Faiz Anwer, Debbie Goldschmidt, Wenxi Tang, David R. Steffen, Binyam Yilma, Samantha Slaff
Journal: Blood
Blood (2022) 140 (Supplement 1): 10916–10917.
https://doi.org/10.1182/blood-2022-158205
Published: 2022
Journal Articles

Investigating Differences in Treatment (Tx) Patterns and Clinical Characteristics Among Patients (Pts) Diagnosed with Multiple Myeloma (MM) Across Racial Groups

Ashley Saunders, Samantha Slaff, Krishnaveni Subbiah, Tao Gu, Michelle A. Quan, Aaron S Rosenberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 13252–13253.
https://doi.org/10.1182/blood-2022-158192
Published: 2022
Journal Articles

Investigating Differences in Clinical Outcomes Among Patients (Pts) Diagnosed with Multiple Myeloma (MM) Across Racial Groups

Ashley Saunders, Samantha Slaff, Krishnaveni Subbiah, Tao Gu, Kwan Ang, Aaron S Rosenberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 13250–13251.
https://doi.org/10.1182/blood-2022-158187
Published: 2022